Aestus Pharmaceuticals India Limited
About Aestus Pharmaceuticals India Limited
Data last updated:
Aestus Pharmaceuticals India Limited is a public limited company based in Chandigarh, India, a subsidiary of Innovative Financial Management Private Limited. It operates in the chemical products segment of the chemicals sector. It was incorporated on 28 June 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2005PLC043164. Its GSTIN is 02AAFCA6433P1ZL (Himachal Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Iqbal Singh (Managing Director) and Amanjot Kaur Chawla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 141 – 42 Sector 9 C, Chandigarh, India – 160009.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.74 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Lakh (net margin 5.9%) and EBITDA of ₹5.86 Lakh (EBITDA margin 29.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Aestus Pharmaceuticals India has one previous CIN (Corporate Identification Number): U24232DL2005PLC138080. The current CIN is U24232CH2005PLC043164, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232CH2005PLC043164 | Current |
| U24232DL2005PLC138080 | Previous |
Contact details
Aestus Pharmaceuticals India Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO 141 – 42 Sector 9 C, Chandigarh, India – 160009
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Aestus Pharmaceuticals India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aestus Pharmaceuticals India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aestus Pharmaceuticals India Limited, buy the company report.
Financials of Aestus Pharmaceuticals India Limited
FY 2025 filings availableAestus Pharmaceuticals India Limited reported revenue of ₹19.74 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 19% growth in the latest year. EBITDA rose 269% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.7% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aestus Pharmaceuticals India Limited, buy the company report.
Board of directors of Aestus Pharmaceuticals India Limited
Aestus Pharmaceuticals India has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amanjot Kaur Chawla Also directs: Ifmsecurities Private Limited, Innovative Financial Management Private Limited, Ifm Investment Advisors Private Limited and 2 more | Director | 01 Aug 2014 | 12 Years 3 Months | Current |
| Inderjit Kaur | Director | 01 Aug 2014 | 12 Years 3 Months | Current |
| Iqbal Singh | Managing Director | 01 Aug 2014 | 12 Years 3 Months | Current |
Auditor
Aestus Pharmaceuticals India Limited is audited by BHARTI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHARTI & ASSOCIATES | FY 2017 | 021553N |
Shareholding
The shareholding of Aestus Pharmaceuticals India Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aestus Pharmaceuticals India Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aestus Pharmaceuticals India Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aestus Pharmaceuticals India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aestus Pharmaceuticals India has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAFCA6433P1ZL | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAFCA6433P1ZJ | Punjab | Active | 25 Mar 2021 |
To see the full GST registrations and return filing status of Aestus Pharmaceuticals India Limited, buy the company report.
Recent activity
Aestus Pharmaceuticals India Limited has 6 board changes on record since 2012: 3 appointments and 3 cessations. The latest: Jag Mohan Mehra ceased to be Director on 03 Nov 2014.
Frequently asked questions
Aestus Pharmaceuticals India is an active public limited company based in Chandigarh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 28 June 2005 (21+ years old) and is registered under CIN U24232CH2005PLC043164.
Aestus Pharmaceuticals India has 3 current directors:
- Iqbal Singh - Managing Director
- Amanjot Kaur Chawla - Director
- Inderjit Kaur - Director
The latest financial statements of Aestus Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aestus Pharmaceuticals India is 02AAFCA6433P1ZL, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 03AAFCA6433P1ZJ (Punjab).
The CIN (Corporate Identification Number) of Aestus Pharmaceuticals India is U24232CH2005PLC043164. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aestus Pharmaceuticals India was incorporated on 28 June 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chandigarh.
Jag Mohan Mehra ceased to be Director on 03 Nov 2014. Amanjot Kaur Chawla was appointed as Director on 01 Aug 2014. Inderjit Kaur was appointed as Director on 01 Aug 2014. Aestus Pharmaceuticals India has 6 board changes on record in total.
The registered office of Aestus Pharmaceuticals India is at SCO 141 – 42 Sector 9 C, Chandigarh, India – 160009.
Aestus Pharmaceuticals India operates in the chemicals industry, in the chemical products segment.
The compliance status of Aestus Pharmaceuticals India is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
